Roivant Sciences (ROIV) Change in Account Payables (2020 - 2025)
Roivant Sciences' Change in Account Payables history spans 6 years, with the latest figure at -$4.0 million for Q4 2025.
- For Q4 2025, Change in Account Payables rose 77.85% year-over-year to -$4.0 million; the TTM value through Dec 2025 reached -$30.7 million, up 10.28%, while the annual FY2025 figure was -$18.2 million, 180.09% down from the prior year.
- Change in Account Payables reached -$4.0 million in Q4 2025 per ROIV's latest filing, down from $3.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $62.9 million in Q3 2021 to a low of -$25.3 million in Q2 2024.
- Average Change in Account Payables over 5 years is $2.9 million, with a median of $1.8 million recorded in 2023.
- The largest YoY upside for Change in Account Payables was 501.0% in 2024 against a maximum downside of 1101.84% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $3.7 million in 2021, then surged by 278.28% to $14.0 million in 2022, then crashed by 87.14% to $1.8 million in 2023, then plummeted by 1101.84% to -$18.0 million in 2024, then surged by 77.85% to -$4.0 million in 2025.
- Per Business Quant, the three most recent readings for ROIV's Change in Account Payables are -$4.0 million (Q4 2025), $3.0 million (Q3 2025), and -$11.7 million (Q2 2025).